BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 20923683)

  • 21. Piglets with maternally derived antibodies from sows immunized with rAdV-SFV-E2 were completely protected against lethal CSFV challenge.
    Xia SL; Du M; Lei JL; Liu Y; Wang Y; Ji S; Xiang GT; Li LF; Cong X; Luo Y; Shao L; Qiu HJ; Sun Y
    Vet Microbiol; 2016 Jul; 190():38-42. PubMed ID: 27283854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A prime-boost vaccination strategy using a Semliki Forest virus replicon vectored DNA vaccine followed by a recombinant adenovirus protects pigs from classical swine fever].
    Sun Y; Liu D; Wang Y; Li N; Li H; Liang B; Qiu H
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):679-85. PubMed ID: 19670635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?
    van Rijn PA
    Vet Microbiol; 2007 Nov; 125(1-2):150-6. PubMed ID: 17561359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus.
    Li N; Zhao JJ; Zhao HP; Sun Y; Zhu QH; Tong GZ; Qiu HJ
    J Virol Methods; 2007 Sep; 144(1-2):73-8. PubMed ID: 17499369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
    Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
    Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
    J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
    Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV.
    Tarradas J; Álvarez B; Fraile L; Rosell R; Muñoz M; Galindo-Cardiel I; Domingo M; Dominguez J; Ezquerra A; Sobrino F; Ganges L
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):243-51. PubMed ID: 21684019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
    Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
    Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
    Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
    J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application.
    Frey CF; Bauhofer O; Ruggli N; Summerfield A; Hofmann MA; Tratschin JD
    Vet Res; 2006; 37(5):655-70. PubMed ID: 16777037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats.
    Toledo JR; Sánchez O; Montesino R; Farnos O; Rodríguez MP; Alfonso P; Oramas N; Rodríguez E; Santana E; Vega E; Ganges L; Frias MT; Cremata J; Barrera M
    J Biotechnol; 2008 Feb; 133(3):370-6. PubMed ID: 18045719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Promising Trigene Recombinant Human Adenovirus Vaccine Against Classical Swine Fever Virus.
    Li H; Gao R; Zhang Y
    Viral Immunol; 2016 May; 29(4):244-51. PubMed ID: 26918463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baculovirus surface display of E(rns) envelope glycoprotein of classical swine fever virus.
    Xu XG; Chiou MT; Zhang YM; Tong DW; Hu JH; Zhang MT; Liu HJ
    J Virol Methods; 2008 Nov; 153(2):149-55. PubMed ID: 18727937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus.
    Li H; Ning P; Lin Z; Liang W; Kang K; He L; Zhang Y
    J Biosci; 2015 Mar; 40(1):79-90. PubMed ID: 25740144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine.
    Risatti GR; Holinka LG; Fernandez Sainz I; Carrillo C; Kutish GF; Lu Z; Zhu J; Rock DL; Borca MV
    Virology; 2007 Aug; 364(2):371-82. PubMed ID: 17418362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.